These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 19121846

  • 1. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
    Pancione M, Forte N, Sabatino L, Tomaselli E, Parente D, Febbraro A, Colantuoni V.
    Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
    [Abstract] [Full Text] [Related]

  • 2. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
    Davidson B, Hadar R, Stavnes HT, Trope' CG, Reich R.
    Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
    [Abstract] [Full Text] [Related]

  • 3. Cytoplasmic beta-catenin accumulation is a good prognostic marker in upper and lower gastrointestinal adenocarcinomas.
    Norwood MG, Bailey N, Nanji M, Gillies RS, Nicholson A, Ubhi S, Darnton JJ, Steyn RS, Womack C, Hughes A, Hemingway D, Harrison R, Waters R, Jankowski JA.
    Histopathology; 2010 Jul; 57(1):101-11. PubMed ID: 20572881
    [Abstract] [Full Text] [Related]

  • 4. Positive KL-6 mucin expression combined with decreased membranous beta-catenin expression indicates worse prognosis in colorectal carcinoma.
    Zhang W, Tang W, Inagaki Y, Qiu M, Xu HL, Li X, Sugawara Y, Nagawa H, Nakata M, Kokudo N.
    Oncol Rep; 2008 Nov; 20(5):1013-9. PubMed ID: 18949395
    [Abstract] [Full Text] [Related]

  • 5. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
    Chen S, Liu J, Li G, Mo F, Xu X, Zhang T, Zhang X, Li J, Han X, Sun Y.
    Scand J Gastroenterol; 2008 Nov; 43(4):456-64. PubMed ID: 18365911
    [Abstract] [Full Text] [Related]

  • 6. Nuclear beta-catenin accumulation as a prognostic factor in Dukes' D human colorectal cancers.
    Miyamoto S, Endoh Y, Hasebe T, Ishii G, Kodama K, Goya M, Ono M, Saitoh N, Chiba T, Ochiai A.
    Oncol Rep; 2004 Aug; 12(2):245-51. PubMed ID: 15254684
    [Abstract] [Full Text] [Related]

  • 7. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
    Choi HN, Kim KR, Lee JH, Park HS, Jang KY, Chung MJ, Hwang SE, Yu HC, Moon WS.
    Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443
    [Abstract] [Full Text] [Related]

  • 8. beta-Catenin, Nf-kappaB and FAS protein expression are independent events in head and neck cancer: study of their association with clinical parameters.
    Rodriguez-Pinilla M, Rodriguez-Peralto JL, Hitt R, Sanchez JJ, Sanchez-Verde L, Alameda F, Ballestin C, Sanchez-Cespedes M.
    Cancer Lett; 2005 Dec 08; 230(1):141-8. PubMed ID: 16253770
    [Abstract] [Full Text] [Related]

  • 9. A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1.
    Cheah PY, Choo PH, Yao J, Eu KW, Seow-Choen F.
    Cancer; 2002 Dec 15; 95(12):2479-86. PubMed ID: 12467060
    [Abstract] [Full Text] [Related]

  • 10. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.
    Gastroenterology; 2009 Jul 15; 137(1):165-75. PubMed ID: 19328798
    [Abstract] [Full Text] [Related]

  • 11. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
    Giaginis C, Katsamangou E, Tsourouflis G, Zizi-Serbetzoglou D, Kouraklis G, Theocharis S.
    Med Sci Monit; 2009 May 15; 15(5):BR148-56. PubMed ID: 19396032
    [Abstract] [Full Text] [Related]

  • 12. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.
    Boo YJ, Park JM, Kim J, Chae YS, Min BW, Um JW, Moon HY.
    Ann Surg Oncol; 2007 May 15; 14(5):1703-11. PubMed ID: 17211730
    [Abstract] [Full Text] [Related]

  • 13. Effects of Dan-shao-hua-xian on expression of PPAR-gamma and NF-kappa B in rat liver fibrosis.
    Wang HY, Cheng ML.
    Hepatobiliary Pancreat Dis Int; 2008 Apr 15; 7(2):179-84. PubMed ID: 18397855
    [Abstract] [Full Text] [Related]

  • 14. Peroxisome proliferator-activated receptor gamma in human prostate carcinoma.
    Nakamura Y, Suzuki T, Sugawara A, Arai Y, Sasano H.
    Pathol Int; 2009 May 15; 59(5):288-93. PubMed ID: 19432669
    [Abstract] [Full Text] [Related]

  • 15. High Pin1 expression is associated with tumor progression in colorectal cancer.
    Kuramochi J, Arai T, Ikeda S, Kumagai J, Uetake H, Sugihara K.
    J Surg Oncol; 2006 Aug 01; 94(2):155-60. PubMed ID: 16847925
    [Abstract] [Full Text] [Related]

  • 16. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.
    Chung GG, Provost E, Kielhorn EP, Charette LA, Smith BL, Rimm DL.
    Clin Cancer Res; 2001 Dec 01; 7(12):4013-20. PubMed ID: 11751495
    [Abstract] [Full Text] [Related]

  • 17. Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer.
    Kawada M, Seno H, Uenoyama Y, Sawabu T, Kanda N, Fukui H, Shimahara Y, Chiba T.
    Cancer Res; 2006 Mar 15; 66(6):2913-7. PubMed ID: 16540637
    [Abstract] [Full Text] [Related]

  • 18. Mechanical loading and delta12prostaglandin J2 induce bone morphogenetic protein-2, peroxisome proliferator-activated receptor gamma-1, and bone nodule formation in an osteoblastic cell line.
    Siddhivarn C, Banes A, Champagne C, Riché EL, Weerapradist W, Offenbacher S.
    J Periodontal Res; 2007 Oct 15; 42(5):383-92. PubMed ID: 17760815
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
    Takeda K, Kinoshita I, Shimizu Y, Ohba Y, Itoh T, Matsuno Y, Shichinohe T, Dosaka-Akita H.
    BMC Cancer; 2008 Nov 08; 8():328. PubMed ID: 18992165
    [Abstract] [Full Text] [Related]

  • 20. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J, Bade S, Hoheisel J, Muley T, Dienemann H, Herpel E.
    Thorac Cardiovasc Surg; 2009 Oct 08; 57(7):403-8. PubMed ID: 19795327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.